Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Bauman

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Journal of Health Care Chaplaincy|August 14, 2008
The role of forgiveness in rehabilitationJohn Bauman
Asian Journal of Andrology|October 1, 2013
Autonomic nerve development contributes to prostate cancer progressionJohn Bauman, Kevin McVary
Oligonucleotides|January 8, 2009
Therapeutic potential of splice-switching oligonucleotidesJohn Bauman, Natee Jearawiriyapaisarn, Ryszard Kole
Microorganisms|September 23, 2022
Compositional Dynamics of Gastrointestinal Tract Microbiomes Associated with Dietary Transition and Feeding Cessation in Lake Sturgeon LarvaeShairah Abdul Razak, Shaley Valentine, Terence Marsh, et al.
Journal of Clinical Pharmacology|July 30, 2013
Evaluation of the effects of food on the single-dose pharmacokinetics of trametinib, a first-in-class MEK inhibitor, in patients with cancerDonna S Cox, Kyri Papadopoulos, Lei Fang, et al.
British Journal of Clinical Pharmacology|March 11, 2014
Concomitant oral and intravenous pharmacokinetics of trametinib, a MEK inhibitor, in subjects with solid tumoursCathrine Leonowens, Carolyn Pendry, John Bauman, et al.
Nucleic Acids Research|February 12, 2013
The small molecule Retro-1 enhances the pharmacological actions of antisense and splice switching oligonucleotidesXin Ming, Kyle Carver, Michael Fisher, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 10, 2002
An aspirin-triggered lipoxin A4 stable analog displays a unique topical anti-inflammatory profileArndt J Schottelius, Claudia Giesen, Khusru Asadullah, et al.
Cancer Chemotherapy and Pharmacology|June 18, 2010
Lack of effect of casopitant on the pharmacokinetics of docetaxel in patients with cancerUday B Dandamudi, Laurel M Adams, Brendan Johnson, et al.
Cancer Immunology Research|April 30, 2014
Chemoimmunotherapy using pegylated liposomal Doxorubicin and interleukin-18 in recurrent ovarian cancer: a phase I dose-escalation studyFiona Simpkins, Aurea Flores, Christina Chu, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Journal of Health Care Chaplaincy|August 14, 2008
The role of forgiveness in rehabilitationJohn Bauman
Asian Journal of Andrology|October 1, 2013
Autonomic nerve development contributes to prostate cancer progressionJohn Bauman, Kevin McVary
Oligonucleotides|January 8, 2009
Therapeutic potential of splice-switching oligonucleotidesJohn Bauman, Natee Jearawiriyapaisarn, Ryszard Kole
Microorganisms|September 23, 2022
Compositional Dynamics of Gastrointestinal Tract Microbiomes Associated with Dietary Transition and Feeding Cessation in Lake Sturgeon LarvaeShairah Abdul Razak, Shaley Valentine, Terence Marsh, et al.
Journal of Clinical Pharmacology|July 30, 2013
Evaluation of the effects of food on the single-dose pharmacokinetics of trametinib, a first-in-class MEK inhibitor, in patients with cancerDonna S Cox, Kyri Papadopoulos, Lei Fang, et al.
British Journal of Clinical Pharmacology|March 11, 2014
Concomitant oral and intravenous pharmacokinetics of trametinib, a MEK inhibitor, in subjects with solid tumoursCathrine Leonowens, Carolyn Pendry, John Bauman, et al.
Nucleic Acids Research|February 12, 2013
The small molecule Retro-1 enhances the pharmacological actions of antisense and splice switching oligonucleotidesXin Ming, Kyle Carver, Michael Fisher, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 10, 2002
An aspirin-triggered lipoxin A4 stable analog displays a unique topical anti-inflammatory profileArndt J Schottelius, Claudia Giesen, Khusru Asadullah, et al.
Cancer Chemotherapy and Pharmacology|June 18, 2010
Lack of effect of casopitant on the pharmacokinetics of docetaxel in patients with cancerUday B Dandamudi, Laurel M Adams, Brendan Johnson, et al.
Cancer Immunology Research|April 30, 2014
Chemoimmunotherapy using pegylated liposomal Doxorubicin and interleukin-18 in recurrent ovarian cancer: a phase I dose-escalation studyFiona Simpkins, Aurea Flores, Christina Chu, et al.
Pageof 2